Vaxart Inc

NASDAQ:VXRT   3:59:59 PM EDT
4.22
-0.07 (-1.63%)
Products

Vaxart Announces Agreement With Hvivo To Develop World’S First Human Omicron Challenge Model

Published: 06/30/2022 12:07 GMT
Vaxart Inc (VXRT) - Vaxart Announces Agreement With Hvivo to Develop World’s First Human Omicron Challenge Model.
Vaxart Inc - Model Will Be Used in Vaxart's Phase Ii Omicron Challenge Trial.
Vaxart Inc - Open Orphan Subsidiary Hvivo to Manufacture Challenge Virus and Conduct Characterization Study.
Vaxart - Subject to Successful Completion of Characterization Study, Omicron Human Challenge Trial Expected to Begin 2023.